October 2005 -  Issue 6                                                                                         Go to EuropaBio home page





Getting Ready for Framework 7
EuropaBio and Hyperion (www.hyperion.ie ) is organising  half-day training courses entitled: Getting Ready for Framework 7. The course will be held in the Hotel Leopold, Rue du Luxembourg, Brussels.  Europabio has negotiated a special rate for our members (200 euro per person instead of the normal fee of 250 euro per person).
For more details of the courses and booking go to:
http://www.europabio.org/events/FP7/EuropaBio%20-%20Hyperion.htm

Great news - European Commission develops its plans for future research programme
The European Commission has set out the details of its proposal for a new programme to fund research and development from 2007 to 2013. The document sets out what the research content and topics will be for red, white and green biotech.  Health will include research for rare diseases including rare forms of widespread diseases, advanced therapies and lots, lots more. These programmes will be discussed with the European Parliament, before being decided on by the Council. Governments are threatening to reduce these research budgets, it will be important for you to encourage them against cutting the research budget; they should find the cuts elsewhere!

Detailed programme (includes info on what you might expect to see covered in future calls for proposals – careful it’s 90 pages!) http://europa.eu.int/comm/research/future/pdf/specifc_programmes/fp7sp_cooperation_en.pdf
Commission Press Release http://europa.eu.int/rapid/pressReleasesAction.do?reference=IP/05/1171&format=HTML&aged=0&language=en&guiLanguage=en

Biotech Policy Day - Industry leaders meet Commissioners
More than 22 CEOs and VPS of biotech and life science companies met with Commissioner Potocnik and Commission Vice President Verheugen to propose and discuss policy measures to improve the environment for biotech in Europe. Both Commissioners gave very encouraging signals. Commissioner Potocnik said that he is convinced of the important role biotech is playing and will play in building the knowledge based economy and called on the industry to lobby national governments to support an increase in research funds under the new Framework Programme.  Commissioner Verheugen told the industry that better Regulation and Biotech were his two top priorities and that the industry could count on his support
Article - Biotechnology debate must remain science-based, says Verheugen


Biotech industry healthcare manifesto published
At a press lunch in Brussels on September 22, EuropaBio launched the healthcare manifesto, setting out the industries policies and demands and calling for implementation of EU rules by Member State Governments. Andrea Rappagliosi, Chair of the Healthcare Council and VP Health Policy Serono presided at the lunch which was attended by some 20 people. This event gave also the opportunity for journalists to meet CEOs of Biopharmaceutical companies and to exchange  the healthcare biotech industry 's views on the European political and legislative agenda.

Press kit - http://www.europabio.org/ne_HCmanifesto.htm
Article - EU regulation on the biotech sector hinders innovation
Article - Patients need innovative medicines, says biotechnology Industry  

 

EuropaBio SMEs interactive with the EMEA, Belgium, Brussels
New legislation including reduction of fees to ease the access of SMEs to the EMEA is expected to be adopted shortly by the EMEA
Before it is officially adopted, EuropaBio organizes an interactive session for SMEs at CORDIA to tell the EMEA about their special needs and expectations.  Come and be heard! Meanwhile the Agency has asked EuropaBio and members of National Associations to complete a questionnaire in order to help the Agency better understand the specific needs and expectations of SMEs.   
Contact – Healthcare Council Manager – Aurelie Vandeputte a.vandeputte@europabio.org

 

National Associations led 'Young Innovative Company' project gets EU funding
The project led by EuropaBio member Per Vretblad head of BioteknikForum and a number of EuropaBio's National Associations (SwedenBIo, Norwegian Bioindustry Association, Estonian Biotech Association  France Biotech, FinBIo) has been approved for funding and starts October 1st. The project aims to develop a plan to introduce the Young Innovative Company Status (YIC) for biotech companies in four Nordic/Baltic countries and to disseminate the experience gained to other parts of Europe.

EU court overturns law to ban GM crops
On October 5th The Court of First Instance has ruled on the case brought by Upper Austria and Austria against the Commission in regard to the former's Article 95 ban on the use of GMOs. The court rejected all four of the applicant's legal pleas, having found them to be misplaced, unfounded, or irrelevant. The court dismissed all of the actions brought by the applicants.
EuropaBio press release - http://www.europabio.org/articles/PR_Austria_051005_FINAL.doc

 

Council fails to vote on biotech maize
On 20th September the EU Agriculture Council of Ministers was unable to reach agreement on the import and processing of 1507 maize, including animal feed use in the European Union.The product is already approved in 12 other countries around the world and meets all the EU’s regulatory requirements, including three positive safety opinions from the European Food Safety Authority (EFSA) for all its intended uses in the EU.
EuropaBio press release http://www.europabio.org/articles/EuropaBio%20PR_maize1507_%200509153.doc

  

EU Energy Commissioner confirms EU looking at fuel situation:
The impact of Hurricane Katrina on
world fuel supplies & prices has prompted the Commission to outline a 5-point plan to address the situation. Outlining the measures in Strasbourg after Commission College meeting, EU Energy Commissioner Andris Piebalgs confirmed that the Commission will concentrate attention on reducing energy demand, but reaffirmed Brussels’ commitment to increasing other forms of energy as a major long-term priority. In this context, he reiterated the Commission’s intention to publish a Biomass Action Plan by the end of the year and a Communication on biofuels tabled by early 2006.
Source: AgraFacts

Food labelling simplification
Commission President José Barroso mentioned in an interview with the Financial Times that the Commission will look at scrapping several draft EU laws including “laws on food labelling and advertising” which have been clarified by DG SANCO officials. In fact, the Commission President was referring to withdrawing a Commission proposal from January 1997 on “amending Directive 79/112/EEC on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs” [COM1997/0020], which has not been discussed in Council since 1997.



Acting EFSA chief
The Management Board of the European Food Safety Authority (EFSA) decided that Dr. Herman Koëter will act as Executive Director of the European Food Safety Authority (EFSA) from November 26 until a permanent successor to outgoing boss Geoffrey Podger is appointed. Currently EFSA’s Deputy Executive Director and Director of Science, the Dutchman previously headed the OECD’s Environment, Health & Safety Division in Paris. The Management Board also appointed Dr. Diane Benford, principal toxicologist of the UK Food Standards Agency (FSA), to the EFSA Panel dealing with Contaminants in the Food Chain.
For more details, see http://www.efsa.eu.int/index_en.html



Money Show, Athens, Greece
BIONOVA Ltd, the National Representative of EuropaBio in Greece, is proud to just have won the 2005 Money Show Prize. Money Show (MS) is a major Greek financial convention (30,000 participants) which the Hellenic-German Chamber of Commerce & Industry organizes in Athens every December since 1992. MS 2005 will take place from December 3- 4 at the Athens Hilton Hotel. The MS Prize distinguishes companies developing innovative concepts with significant economic potential. The award acknowledges BIONOVA's efforts to champion bio-business awakening, recruit local biotech players under the EuropaBio association, and ultimately catalyze biotech value creation in Greece. For further details visit www.moneyshow.org.
 





9-11 October 2005 - CORDIA and BioPartnering Europe, London, UK
EuropaBio supports BioPartnering Europe (BPE) and CORDIA to be held consecutively October 9-11 and October 11-13 in London   BioPartnering Europe (BPE) is Europe’s longest running partnering event and CORDIA is a high-level business conference and an international exhibition to promote your research and services to new business partners and suppliers from a diverse range of global companies.
EuropaBio members entitled to a 10% discount on BPE registration and a 15% discount on CORDIA registration
BioPartnering Europe
- http://www.techvision.com/bpe/about/  
CORDIA -
www.cordiaconvention.com


18-20 October - BIOTECHNICA 2005 - International Trade Fair for Biotechnology, Hannover, Germany
Most important biotechnology exposition in Europe with about 1.000 exhibitors and 13.000 visitors from 25 countries. Fields of applications: Pharmaceuticals/Medicine, Environment, Agriculture, Food/Nutrition, Bioinformatics, Services, Equipment .
ttp://www.biotechnica.de


25-27 October 2005 – Sixth Workshop on Partnering for Rare Disease Therapy Development, London, UK
This high level workshop will bring together representatives from key stakeholder groups –  patients, regulators, charities, the academic and clinical community, industry and health care providers – from across Europe and North America and from the rest of the world. For more information or to register go to: www.epposi.org.

3 November 2005 - Innovative Science for Successful Business - 2nd Partnering Day for Biomedical Research
The Partnering Day 2005 will offer the opportunity to present your technological know-how to regional and international enterprises and research organisations in the sectors of biotechnology, pharmaceutical industry, medical and biomedical technology, medical and molecular diagnostics, medical informatics as well as implantation and transplantation technologies.
http://www.europabio.org/events/Nov03_2005.htm



7-
9 November 2005 Bio-Europe 2005, Dresden, Germany
BIO-Europe is a forum where international decision makers in the biotechnology, pharmaceutical, and financial sector can meet to initiate or develop partnerships among their companies. http://www.ebdgroup.com/bioeurope/



8-9 November - Tissue Engineering events and EuropaBio Industry Hearing, Brussels, Belgium
Two day conference on marketing and business development strategies for tissue engineered products comprising interactive panel discussions and networking opportunities which includes access to the EuropaBio Industry Hearing on new EU rules on tissue engineered products.
EuropaBio Industry Hearing:
€400 for non members €300 for EuropaBio members and members of National Associations
Full Conference plus Industry Hearing: Price: £1596 (GBP)
Full Conference Special Offer for EuropaBio members and members of National Associations: 1496GBP
http://www.europabio.org/events/IndustryHearing091105.asp

28–30 November 2005 - European Biotech Crossroads, Lille, France
The 2005 edition will offer the biotechnology community a unique occasion to share new scientific knowledge, foster innovation, gather funding and seize new market opportunities. 
EuropaBio members entitled to a 15% discount on Crossroads registration
http://www.europeanbiotechcrossroads.com

 

1 December 2005 - 10th Biotech & Finance Forum, Spain
The Biotech & Finance Forum has established itself as the pan-European initiative allowing innovative biotech and life science businesses from across Europe to meet in a very pragmatic and direct way with an extensive audience of Europe's leading life sciences and biotech investors as well as senior executives from top pharmaceutical firms. As a long running initiative of the European Commission, the BFF is organised by Europe Unlimited in association with EuropaBio. http://www.europabio.org/events/December1_2005.htm



2 December 2005 – Industrial Biotech Forum
EuropaBio is coorganiser of this unique initiative in Europe the Industrial Biotech & Finance Forum which will gather key stakeholders from Europe's innovative Industrial Biotech venturing to foster dynamic entrepreneurship and growth in this highly active industry. The Forum will provide an open channel of communication for exchange of information, best practices and deal-making and will e stablish clear models for VC investment into industrial biotech.
Special resgistration rates for EuropaBio members
.
http://www.europabio.org/events/December2_2005.htm

8-10 March 2006 – BioSquare 2006  
A unique platform for the top management of biotechnology companies to meet with key research and business development executives from the pharmaceutical, nutraceutical, agriculture, food, and finance industries.
http://www.europabio.org/events/March8_2006.htm

 

9-12 April 2005 -BIO Annual International Convention, Chicago, USA
All events will take place at the McCormick Place Convention Center unless noted otherwise. The McCormick Place Convention Center is located at 2301 South Lake Shore Drive, Chicago, IL.
http://www.europabio.org/events/April9_06.htm


14-17 May 2006 – SciPharm 2006, Edinburgh, UK
This event is the second meeting in the series covering all aspects of innovation in the pharmaceutical industry.  The conference will examine the latest advances in drug discovery and development through three science based tracks.  The fourth track, where science meets business will focus on promoting the flow of ideas and products between small and large players in the industry and the routes for turning research into products.http://www.europabio.org/events/May14_2006.htm

 

Calendar of all other upcoming events in the biotech sector – click here
http://www.europabio.org/ev_calendar.htm



 

If you do not want to receive this information again, please click here

If you have any questions, comments or suggestions please send a message to: a.cornea@europabio.org

All password protected documents are available to EuropaBio members only. If you want to become a EuropaBio member please visit the EuropaBio membership page at: http://www.europabio.org/eu_join.htm